Danaher Announces Quarterly Dividend
Danaher Corporation (NYSE: DHR) has announced its Board of Directors approved a regular quarterly cash dividend of $0.32 per share of common stock. The dividend will be paid on October 31, 2025 to shareholders of record as of September 26, 2025.
Danaher Corporation (NYSE: DHR) ha annunciato che il Consiglio di Amministrazione ha approvato un dividendo in contanti trimestrale ordinario di $0.32 per azione. Il dividendo sar脿 corrisposto il 31 ottobre 2025 agli azionisti iscritti al registro al 26 settembre 2025.
Danaher Corporation (NYSE: DHR) ha anunciado que su Junta Directiva aprob贸 un dividendo ordinario en efectivo trimestral de $0.32 por acci贸n. El dividendo se pagar谩 el 31 de octubre de 2025 a los accionistas registrados al 26 de septiembre de 2025.
Danaher Corporation (NYSE: DHR)電� 鞚挫偓須岅皜 鞝曣赴 攵勱赴 順勱笀 氚半嫻旮� 欤茧嫻 $0.32毳� 鞀轨澑頄堧嫟瓿� 氚滍憸頄堨姷雼堧嫟. 氚半嫻旮堨潃 2025雲� 10鞗� 31鞚�鞐� 2025雲� 9鞗� 26鞚� 順勳灛 欤检＜氇呺秬鞐� 霌膘灛霅� 欤检＜霌れ棎瓴� 歆�旮夒惄雼堧嫟.
Danaher Corporation (NYSE: DHR) a annonc茅 que son conseil d'administration a approuv茅 un dividende trimestriel en num茅raire ordinaire de $0.32 par action. Le dividende sera vers茅 le 31 octobre 2025 aux actionnaires inscrits au registre au 26 septembre 2025.
Danaher Corporation (NYSE: DHR) hat angek眉ndigt, dass sein Vorstand eine regul盲re viertelj盲hrliche Bardividende von $0.32 pro Aktie genehmigt hat. Die Dividende wird am 31. Oktober 2025 an Aktion盲re ausgezahlt, die am 26. September 2025 im Register verzeichnet sind.
- Regular quarterly dividend of $0.32 per share demonstrates consistent shareholder returns
- Maintains dividend payment schedule showing financial stability
- None.
ABOUT DANAHER
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our approximately 63,000 associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. Explore more at聽.
View original content:
SOURCE Danaher Corporation
FAQ
What is Danaher's (DHR) dividend amount for Q4 2025?
When is the ex-dividend date for Danaher's (DHR) Q4 2025 dividend?
When will Danaher (DHR) pay its Q4 2025 dividend?
Who is eligible to receive Danaher's (DHR) Q4 2025 dividend?
